Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 994 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22,646 | 25,554 |
| Total Cites | 66,435 | 70,590 |
| H-index | 114 | 116 |
| Hm-index | 22 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 57 | 59 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1,136 | 1,196 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 18,043 | 18,851 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 57,186 | 59,645 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
5.89%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 962 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21,367 | 24,431 |
| Total Cites | 62,896 | 67,000 |
| H-index | 113 | 114 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 55 | 57 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1,120 | 1,180 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 16,829 | 17,621 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 54,143 | 56,569 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
6.13%
|
|
Sellers, William R.
Novartis Institutes for BioMedical Research, Inc.,
United States
2023 Rank: 20,684
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 945 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20,684 | 23,048 |
| Total Cites | 59,361 | 63,374 |
| H-index | 109 | 112 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 54 | 56 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1,096 | 1,156 |
| Number of Single+First+Last Authored Papers | 68 | 68 |
| Total Cites to Single+First+Last Authored Papers | 15,676 | 16,448 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 51,059 | 53,427 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
6.33%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 877 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19,162 | 21,781 |
| Total Cites | 55,065 | 58,925 |
| H-index | 107 | 109 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 53 | 55 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1,079 | 1,139 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 14,310 | 15,028 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 47,373 | 49,648 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
6.55%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 864 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,754 | 21,071 |
| Total Cites | 52,784 | 56,549 |
| H-index | 104 | 106 |
| Hm-index | 21 | 22 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 53 | 55 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1,064 | 1,122 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 13,639 | 14,327 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 45,429 | 47,655 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
6.66%
|
|
Sellers, William R.
Novartis Institutes for BioMedical Research, Inc.,
United States
2020 Rank: 18,158
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Developmental Biology
Rank in SubField 1: 899 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,158 | 20,647 |
| Total Cites | 47,806 | 51,398 |
| H-index | 99 | 102 |
| Hm-index | 20 | 21 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 50 | 52 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 1,042 | 1,099 |
| Number of Single+First+Last Authored Papers | 61 | 61 |
| Total Cites to Single+First+Last Authored Papers | 12,191 | 12,817 |
| Composite Score | 3 | 4 |
| Number of Distinct Citing Papers | 41,121 | 43,253 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
6.99%
|
|
Trending Researchers
.jpeg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.